Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.

Sanjay Sethi Brendan ClarkLindsay G S BengtsonErin K BuysmanSwetha PalliAndrew SargentAsif ShaikhGary T Ferguson

Published in: International journal of chronic obstructive pulmonary disease (2023)

These real-world results support ATS and GOLD recommendations for treating low-exacerbation risk COPD patients with dual bronchodilators and TT for more severe, higher-exacerbation risk COPD patients.

Keyphrases

chronic obstructive pulmonary disease
healthcare
end stage renal disease
newly diagnosed
ejection fraction
lung function
prognostic factors
peritoneal dialysis
early onset
intensive care unit
clinical practice
patient reported outcomes
silver nanoparticles
respiratory failure